The Latest Cardiac and Vascular News
MONMOUTH JUNCTION, N.J., Dec. 21, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Professor Daniel Wendt, MD, PhD, MHBA, FETCS as Vice President, Medical Affairs Cardiovascular commencing January 1, 2022. Dr. Wendt is an internationally renowned […]
Equity investment to support advancement of its breakthrough full-body embolic protection device to reduce the risk of stroke and other complications during left-heart procedures. CAESAREA, Israel, Dec. 21, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European […]
First enrollment comes as investors provide $75M toward an oversubscribed Series C financing NEWTON, Mass., Dec. 20, 2021 /PRNewswire/ — Affera Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that the first patient was treated in the recently approved SPHERE PerAF Trial, a U.S. Food and […]
CALGARY, AB, Dec. 20, 2021 /PRNewswire/ – Canadian Pacific (CP) is proud to announce that fundraising efforts over the past two years for the CP Women’s Open (CPWO) have helped raise more than $2.8 million to support important equipment purchases and research at BC Children’s Hospital, along with an additional $557,000 for Kamloops Royal Inland Hospital. […]
JI XING to Develop and Commercialize Novel Cardiac Myosin Activator in Patients with Heart Failure Cytokinetics to Receive $70 Million in Committed Capital; Up to an Additional $330 Million in Potential Milestone Payments Plus Royalties Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time SOUTH SAN […]
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma Partners Investment will fund clinical studies of ARMGO’s lead molecule ARM210, an oral treatment, in development for cardiac and skeletal […]
Acarix AB (“Acarix” or the “Company”) has completed the new share issue of a maximum of 105 784 311 shares with preferential rights for the Company’s existing shareholders, which was resolved by the extra general meeting on 23 November 2021 (the “Rights Issue”). Acarix today announces the final outcome of […]
Closes Successful $16.5 Million IPO and Commences Trading on the Nasdaq SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, has reported its financial and operational results for the third quarter and nine months […]
Cordis continues leadership team buildout with seasoned healthcare finance officer MIAMI LAKES, Fla., Dec. 16, 2021 /PRNewswire/ — Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Financial Officer. He will be responsible for leading the company’s financial and IT functions and will play an instrumental […]
Funds Support Completion of Pivotal Clinical Trial of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure CAESAREA, Israel and AGOURA, Calif., Dec. 16, 2021 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced […]
